Outcomes after the long interdialytic break: Implications for the dialytic prescription

Seminars in Dialysis

Volumn 25, Issue 1, 2012, Pages 1-8

  Flythe, Jennifer E ^a   Lacson, Eduardo ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856259214     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.01015.x     Document Type: Editorial

References (82)

1. Bleyer AJ, Russell GB, Satko SG: Sudden and cardiac death rates in hemodialysis patients. Kidney Int 55:1553-1559, 1999.
2. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G: Characteristics of sudden death in hemodialysis patients. Kidney Int 69:2268-2273, 2006.
3. Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C, Lazaraus JM, Chertow GM: Cardiac arrest and sudden death in dialysis units. Kidney Int 60:350-357, 2001.
4. Genovesi S, Valsecchi MG, Rossi E, Pogliani D, Acquistapace I: Sudden death and associated factors in a historical cohort of chronic hemodialysis patients. Nephrol Dial Transplant 24:2529-2536, 2009.
5. Foley RN, Gilbertson DT, Murray T, Collins AJ: Long interdialytic interval and mortality among patients receiving hemodialysis. NEJM 365(12):1099-1107, 2011.
6. Ruscone TG, Piccaluga E, Guzzetti S, Contini M, Montano N, Nicolis E, on behalf of GISSI 2 Study Investigators: Morning and Monday: critical periods for the onset of acute myocardial infarction. The GISSI 2 Study experience. Eur Heart J 15:882-887, 1994.
7. Willich SN, Lowel H, Lewish M, Hormann A, Arntz HR, Keil U: Weekly variation of acute myocardial infarctions: increased Monday risk in the working population. Circulation 90:87-94, 1994.
8. Muller JE, Stone PH, Rutherford TG, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T, Sobel BE, Willerson JT, Braunwald E: Circadian variation in the frequency of onset of acute myocardial infarction. New Engl J Med 313:1315-1322, 1985.
9. Turton MB, Deegan T: Circadian variation of plasma catecholamine, cortisol, and immunoreactive insulin concentration in supine subjects. Clin Chim Acta 55:389-397, 1974.
10. Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L: Twenty-four hour patterns of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 33:14-22, 1971.
11. Miller-Craig MW, Bishop CN, Raftery EB: Circadian variation of blood pressure. Lancet 1:795-797, 1978.
12. Wertheimer L, Hassen AZ, Delman AJ: The 24-hour (circadian) rhythm of the cardiovascular system. Clin Res (abstract), 20:404, 1972.
13. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, Shanahan CM: Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118:1748-1757, 2008.
14. Pecoits-Filho R, Heimburger O, Barany P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P: Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 41:1212-1218, 2003.
15. Daugirdas JT: Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 38:S11-S17, 2001.
16. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanellii B, Malatino LS: Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105:1354-1359, 2002.
17. Kesheviah PR, Nolph KD, Van Stone JC: The peak concentration hypothesis: a urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis and hemodialysis. Perit Dial Int 9(4):257-260, 1989.
18. Sherman RA: The peak concentration hypothesis-a justification for inadequate therapy? Semin Dial 7:318-320, 1994.
19. Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP: Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int 79:218-227, 2011.
20. Morrison G, Michelson EL, Brown S, Morganroth J: Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 17:811-819, 1980.
21. Lorincz I, Maytus J, Zilahi Z, Kun C, Karanyi Z, Kakuk G: QT dispersion in patients with end-stage renal failure and during hemodialysis. J Am Soc Nephrol 10:1297-1302, 1999.
22. Cupisti A, Galetta F, Caprioli R, Morelli E, Tintori GC, Franzoni F, Lippi A, Meola M, Rindi P, Barsotti G: Potassium removal increases the QTc interval dispersion during hemodialysis. Nephron 82:122-126, 1999.
23. Morris S, Galiatsou E, Stewart GA, Rodger RS, Jardine AG: QT dispersion before and after hemodialysis. J Am Soc Nephrol 10:160-163, 1999.
24. Buemi M, Aloisi E, Coppolino G, Loddo S, Crasci E, Aloise C, Barilla A, Cosentini V, Nostro L, Caccamo C, Floccari F, Romeo A, Frisina N, Teti D: The effect of two different protocols of potassium haemodiafiltration on QT dispersion. Nephrol Dial Transplant 20:1148-1154, 2005.
25. Rombola G, Colussi G, De Ferrari ME, Frontini A, Minetti L: Cardiac arrhythmias and electrolyte changes during haemodialysis. Nephrol Dial Transplant 7:318-322, 1992.
26. Butkus DE, Alfrey AC, Miller NL: Tissue potassium in chronic dialysis patients. Nephron 13:314-324, 1974.
27. Johny KV, Lawrence JR, O'Halloran MW, Wellby ML, Worthley BW: Studies on total body, serum and erythrocyte potassium in patients on maintenance haemodialysis. The value of erythrocyte potassium as a measure of body potassium. Nephron 7:230-240, 1970.
28. Cohen JD, Neaton JD, Preineas RJ, Daniels KA, the Multiple Risk Factor Intervention Trial Research Group: Diuretics, serum potassium and ventricular arrhythmia in the multiple risk factor intervention trial. JAMA 60:548-554, 1982.
29. Paoletti E, Specchia C, Di Maio G: The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10year survey. Nephrol Dial Transplant 19:1829-1834, 2004.
30. Haider AW, Larson MG, Benjamin EJ, Levy D: Increased left ventricular mass and hypertrophy are associated with an increased risk for sudden death. J Am Coll Cardiol 32:1454-1459, 1998.
31. Cameron JS, Myerburg RJ, Wong SS: Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overload. J Am Coll Cardiol 2:481-487, 1983.
32. Nordin C, Siri F, Aronson RS: Electrophysiologic characteristics of single myocytes isolated from hypertrophied guinea-pig hearts. J Mol Cell Cardiol 21:729-739, 1989.
33. Gillis AM, Mathison HJ, Kulisz E, Lester WM: Dispersion of ventricular repolarization and ventricular fibrillation in left ventricular hypertrophy: influence of selective potassium channel blockers. J Pharmacol Exp Ther 292:381-386, 2000.
34. Li Q, Keung EC: Effects of myocardial hypertrophy on transient outward current. Am J Physiol 266(5 Pt 2):H1738-H1745, 1994.
35. Ben-David J, Zipes DP, Ayers GM, Pride HP: Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early after depolarizations after administration of BAY K 8644. J Am Coll Cardiol 20:1576-1584, 1992.
36. Charpentier F, Baudet S, Le Marec H: Triggered activity as a possible mechanism for arrhythmias in ventricular hypertrophy. Pacing Clin Electrophysiol 14:1735-1741, 1991.
37. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69:1222-1228, 2006.
38. Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fischer MS, Londrino F, Cancarini G: Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 22:3547-3552, 2007.
39. Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79:250-257, 2011.
40. Flythe JE, Brunelli SM: The risks of high ultrafiltration rate in chronic hemodialysis: implications for patient care. Semin Dial 24(3):259-265, 2011.
41. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4:914-920, 2009.
42. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 4:1925-1931, 2009.
43. Selby NM, Burton JO, Chesterton LJ, McIntyre CW: Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 1:1216-1225, 2006.
44. Selby NM, Lambie SH, Camici PG, Baker CS, McIntyre CW: Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis 47:830-841, 2006.
45. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50:600-608, 1996.
46. London GM, Drueke TB: Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 51:1678-1695, 1997.
47. U.S. Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.
48. Maynard JC, Cruz C, Kleerekoper M, Levin NW: Blood pressure response to changes in serum ionized calcium during hemodialysis. Ann Intern Med 104:358-361, 1986.
49. Fellner SK, Lang RM, Neumann A, Spencer KT, Bushinsky DA, Borow KM: Physiological mechanism for calcium-induced changes in systemic arterial pressure in stable dialysis patients. Hypertenstion 13:213-218, 1989.
50. Leunissen KML, van den Berg BW, van Hoof JP: Ionized calcium plays a pivotal role in controlling blood pressure during hemodialysis. Blood Purif 7:233-239, 1989.
51. Henrich WL, Hunt JM, Nixon JV: Increased ionized calcium and left ventricular contractility during hemodialysis. N Engl J Med 310:19-23, 1984.
52. Van Kuijk WHM, Mulder AW, Peels CH, Harff GH, Leunissen KML: Influence of changes in ionized calcium on cardiovascular reactivity during hemodialysis. Clin Nephrol 47:190-196, 1997.
53. Van der Sande FM, Cheriex EC, van Kuijk WHM, Leunissen KML: Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients. Am J Kidney Dis 32:125-131, 1998.
54. Malberti F, Ravani P: The choice of the dialysate calcium concentration in the management of patients on hemodialysis and hemodiafiltration. Nephrol Dial Transplant 18(Suppl 7):vii37-vii40, 2003.
55. Goldsmith RS, Furszfer J, Johnson WJ, Beeler GW, Taylor WF: Calcium flux during dialysis. Nephron 20:132-140, 1978.
56. Messa P, Alfieri C, Brezzi B: Cinacalcet: pharmacological and clinical aspects. Expert Opin Drug Metab Toxicol 4:1551-1560, 2008.
57. Sigrist MK, Devlin L, Taal MW, Fluck RJ, McIntyre CW: Length of interdialytic interval influences serum calcium and phosphorus concentrations. Nephrol Dial Transplant 20:1643-1646, 2005.
58. Ring T, Sanden AK, Hansen HHT, Halkier HP, Nielsen C, Fog L: Ultradian variation in serum phosphate concentration in patients on haemodialysis. Nephrol Dial Transplant 10:59-63, 1995.
59. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112(17):2627-2633, 2005.
60. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL: Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520-528, 2005.
61. Di Benedetto A, Marcelli D, D'Andrea A, Cice G, D'Isa S, Cappabianca F, Pacchiano G, D'Amato R, Oggero AR, Bonanno D, Pergamo O, Calabrò R: Risk factors and underlying cardiovascular diseases in incident ESRD. J Nephrol 18:592-598, 2005.
62. Lim VS, Flanigan MJ: The effect of interdialytic interval on protein metabolism: evidence suggesting dialysis-induced catabolism. Am J Kidney Dis 14(2):96-100, 1989.
63. Graham KA, Hoenich NA, Goodship TH: Pre- and interdialytic acid-base balance in hemodialysis patients. Int J Artif Organs 24:192-196, 2001.
64. Ramkumar N, Beddhu S, Eggers P, Pappas LM, Cheung AK: Patient preferences for in-center intense hemodialysis. Hemodial Int 9:281-295, 2005.
65. FHN Trial Group: In-center hemodialysis six times per week versus three times per week. New Engl J Med 363(24):2287-2300, 2010.
66. Mastrangelo F, Alfonso L, Napoli M, DeBlasi V, Russo F, Patruno P: Dialysis with increased frequency of sessions (Lecce dialysis). Nephrol Dial Transplant 13(Suppl 6):139-147, 1998.
67. Kerr PG, Agar JWM, Hawley CM. Alternate night nocturnal hemodialysis: the Australian experience. Semin Dial [Epub ahead of print, Nov 22: doi:], 2011.
68. Van Eps CL, Jeffries JK, Anderson JA, Bergin PT, Johnson DW, Campbell SB, Carpenter SM, Isbel NM, Mudge DW, Hawley CM: Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology (Carlton) 12:224-233, 2007.
69. Tang HL, Wong JH, Poon CK, Tang CM, Chu KH, Lee W, Fung SK, Chau KF, Tong KL: One year experience of nocturnal home haemodialysis with an alternate night schedule in Hong Kong. Nephrology (Carlton) 16:57-62, 2011.
70. Medicare Benefit Policy Manual, Chapter 11 - End Stage Renal Disease. Available at, accessed January 28, 2011.
71. Lacson E, Wang W, Lester K, Ofsthun N, Lazarus JM, Hakim RM: Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Clin J Am Soc Nephrol 5:220-226, 2010.
72. Singhal PC, Desroches L, Mattana J, Abramovici M, Wagner JD, Maesaka JK: Mineralocorticoid therapy lowers serum potassium in patients with end stage renal disease. Am J Nephrol 13:138-141, 1993.
73. Mathialahan T, Sandle GI: Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease. Nephrol Dial Transplant 18:341-347, 2003.
74. Farese S, Kruse A, Pasch A, Dick B, Frey BM, Uehlinger DE, Frey FJ: Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients. Kidney Int 76:877-884, 2009.
75. Stewart PM, Wallace AM, Vanentino R, Burt D, Shackleton CH, Edwards CR: Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 10:821-824, 1987.
76. Farese RV, Biglieri EG, Shackleton CH, Irony I, Gomez-Gontes R: Licorice-induced hypermineralocorticoidism. N Engl J Med 325:1223-1227, 1991.
77. Filiopoulos V, Koutis I, Trompouki S, Hadjiyannakos D, Lazarou D, Vlassopoulos D: Lanthanum carbonate versus sevelamer hydrochloride: improvement of metabolic acidosis and hyperkalemia in hemodialysis patients. Ther Apher Dial 15:20-27, 2011.
78. De Nicola L, Bellizzi V, Minutolo R, Cioffi M, Giannattasio P, Terracciano V, Iodice C, Uccello F, Memoli B, Iorio BR, Conte G: Effect of dialysate sodium concentration on interdialytic increase of potassium. J Am Soc Nephrol 11:2337-2343, 2000.
79. Keen ML, Gotch FA: The association of the sodium "setpoint" to interdialytic weight gain and blood pressure in hemodialysis patients. Int J Artif Organs 30:971-979, 2007.
80. Mendoza JM, Sun S, Chertow GM, Moran J, Doss S, Schiller B: Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? Nephrol Dial Transplant 26:617-626, 2011.
81. Mendoza JM, Bayes LY, Sun S, Doss S, Schiller B: Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly in-center nocturnal hemodialysis: a quality improvement study. Am J Kidney Dis 58(6):956-963, 2011.
82. Redaelli B, Locatelli F, Limido D, Andrulli S, Signorini MG, Sforzini S, Bonoldi L, Vincenti A, Cerutri S, Orlandini G: Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. Kidney Int 50:609-617, 1996.